TWD
KURA icon

True Wealth Design’s Kura Oncology KURA Stock Holding History

True Wealth Design’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
1,242
+375
+43% +$3.54K ﹤0.01% 955
2026
Q1 		$7.05K Sell
867
-462
-35% -$3.97K ﹤0.01% 1091
2025
Q4 		$13.8K Buy
1,329
+497
+60% +$5.21K ﹤0.01% 741
2025
Q3 		$7.36K Buy
832
+17
+2% +$121 ﹤0.01% 945
2025
Q2 		$4.7K Sell
815
-437
-35% -$2.68K ﹤0.01% 832
2025
Q1 		$8.26K Buy
1,252
+1,243
+13,811% +$9.69K ﹤0.01% 534
2024
Q4 		$79 Sell
9
-101
-92% -$1.45K ﹤0.01% 1293
2024
Q3 		$2.15K Buy
+110
New +$2.23K ﹤0.01% 765

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

True Wealth Design's KURA Position: Q2 2026 in Review

True Wealth Design increased its Kura Oncology (KURA) stake by 43% in Q2 2026, buying an estimated $3.54K and bringing the position to 1,242 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #955.

True Wealth Design first reported a position in KURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $13.8K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • True Wealth Design held 1,242 shares of Kura Oncology worth $13.6K as of Q2 2026.
  • True Wealth Design bought 375 Kura Oncology shares in Q2 2026, an estimated $3.54K.
  • Kura Oncology made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #955 holding.
  • True Wealth Design first reported a position in Kura Oncology in Q3 2024 and has held it in 8 quarters since.
  • True Wealth Design's Kura Oncology position peaked at $13.8K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.